ABBOTINDIA 27601.00 -194.60(-0.70%)
ADANIGREEN 1940.90 -7.80(-0.40%)
ADANIPORTS 1404.95 -23.65(-1.66%)
AMBUJACEM 605.00 -14.70(-2.37%)
APOLLOHOSP 7068.70 +35.40(0.50%)
ASHOKLEY 235.80 -0.15(-0.06%)
ASIANPAINT 3302.45 +28.25(0.86%)
ASTRAL 1897.55 +1.90(0.10%)
AUBANK 736.00 +12.60(1.74%)
AUROPHARMA 1514.25 -24.50(-1.59%)
AXISBANK 1240.95 +2.60(0.21%)
BAJAJ-AUTO 11873.45 +107.30(0.91%)
BAJAJFINSV 1892.85 +5.35(0.28%)
BAJAJHLDNG 10782.70 +413.55(3.99%)
BAJFINANCE 7583.25 -49.00(-0.64%)
BANDHANBNK 210.00 -3.10(-1.45%)
BANKBARODA 234.80 -2.95(-1.24%)
BERGEPAINT 621.55 +1.60(0.26%)
BHARATFORG 1560.85 -15.45(-0.98%)
BHARTIARTL 1670.15 +17.50(1.06%)
BOSCHLTD 34394.00 -310.00(-0.89%)
BPCL 326.65 -9.25(-2.75%)
BRITANNIA 6204.30 +83.25(1.36%)
CHOLAFIN 1589.50 +1.70(0.11%)
CIPLA 1653.00 +1.10(0.07%)
COALINDIA 478.70 -8.15(-1.67%)
COFORGE 6903.75 +44.50(0.65%)
COLPAL 3628.25 -4.45(-0.12%)
CONCOR 905.40 -22.05(-2.38%)
CUMMINSIND 3664.50 -99.00(-2.63%)
DABUR 659.95 +5.75(0.88%)
DIVISLAB 5450.30 -18.00(-0.33%)
DMART 5196.55 -69.55(-1.32%)
DRREDDY 6546.05 -22.20(-0.34%)
DLF 839.15 -21.45(-2.49%)
EICHERMOT 4864.50 +14.25(0.29%)
FEDERALBNK 182.80 -2.95(-1.59%)
GAIL 210.50 -7.25(-3.33%)
GODREJCP 1441.10 +8.00(0.56%)
GODREJPROP 2821.45 -63.80(-2.21%)
GRASIM 2723.45 -0.80(-0.03%)
HAVELLS 1991.80 +3.10(0.16%)
HDFCAMC 4332.30 -98.90(-2.23%)
HDFCBANK 1710.25 +15.90(0.94%)
HDFCLIFE 703.70 +4.70(0.67%)
HEROMOTOCO 6015.00 +50.20(0.84%)
HCLTECH 1733.70 -21.95(-1.25%)
HINDALCO 676.20 -8.90(-1.30%)
HINDPETRO 398.55 -8.75(-2.15%)
HINDUNILVR 2922.15 +45.70(1.59%)
ICICIBANK 1290.00 +1.95(0.15%)
ICICIGI 2173.65 +32.80(1.53%)
ICICIPRULI 758.05 +6.70(0.89%)
IDEA 10.59 -2.32(-17.97%)
IDFCFIRSTB 72.56 -0.22(-0.30%)
INDHOTEL 677.50 -3.80(-0.56%)
INDUSINDBK 1485.80 +6.20(0.42%)
INFY 1887.00 -5.35(-0.28%)
ITC 509.30 +2.25(0.44%)
JSWSTEEL 947.20 -8.40(-0.88%)
JUBLFOOD 677.15 +1.95(0.29%)
KOTAKBANK 1856.40 +17.35(0.94%)
LT 3685.70 -43.95(-1.18%)
LTTS 5515.70 +39.25(0.72%)
LUPIN 2170.35 -54.00(-2.43%)
M&M 2799.15 -9.65(-0.34%)
MARICO 692.70 -3.15(-0.45%)
MARUTI 12373.95 +173.75(1.42%)
MPHASIS 2966.20 -40.85(-1.36%)
MRF 134932.05 +730.80(0.54%)
MUTHOOTFIN 2046.20 +27.90(1.38%)
NAUKRI 7805.90 +64.15(0.83%)
NESTLEIND 2647.95 +53.20(2.05%)
NMDC 210.10 -2.15(-1.01%)
NTPC 423.45 +9.60(2.32%)
ONGC 284.65 -5.45(-1.88%)
PAGEIND 42850.05 -136.60(-0.32%)
PEL 1044.20 -36.85(-3.41%)
PERSISTENT 5218.50 +40.95(0.79%)
PGHH 16638.20 +73.90(0.45%)
PIDILITIND 3207.85 +17.15(0.54%)
PIIND 4674.00 +19.35(0.42%)
PNB 106.70 -2.00(-1.84%)
PNBHOUSING 1010.20 -65.80(-6.12%)
POLYCAB 6501.95 -161.85(-2.43%)
POWERGRID 333.20 -1.00(-0.30%)
RELIANCE 2941.05 +14.80(0.51%)
SBICARD 784.20 +4.70(0.60%)
SBILIFE 1838.40 -4.30(-0.23%)
SBIN 786.95 -5.40(-0.68%)
SHREECEM 24795.95 -220.05(-0.88%)
SIEMENS 6560.35 -174.90(-2.60%)
SRF 2388.80 +0.15(0.01%)
SUNPHARMA 1860.25 -5.65(-0.30%)
TATACONSUM 1214.60 +13.95(1.16%)
TATACHEM 1002.00 -15.45(-1.52%)
TATAMOTORS 957.90 -4.50(-0.47%)
TATAPOWER 433.95 -6.70(-1.52%)
TATASTEEL 148.60 -2.00(-1.33%)
TCS 4289.75 -56.85(-1.31%)
TECHM 1596.80 -8.55(-0.53%)
TITAN 3768.75 +45.10(1.21%)
TORNTPHARM 3329.90 -30.45(-0.91%)
TTML 85.84 -2.51(-2.84%)
ULTRACEMCO 11600.00 -33.55(-0.29%)
UBL 2122.60 +73.60(3.59%)
UPL 588.65 -16.20(-2.68%)
VEDL 445.15 -3.00(-0.67%)
VOLTAS 1912.70 +22.60(1.20%)
WIPRO 531.15 -6.65(-1.24%)
YESBANK 22.89 -0.41(-1.76%)
ZEEL 127.00 -4.25(-3.24%)
ZYDUSLIFE 1047.70 -31.65(-2.93%)

FII Data: Stock Market Insights on 28 Aug 2024 -GMM Pfaudler

Image is loading
Image is loadingImage is loadingImage is loading
Foreign Investment(buy/sell) Trends of Today’s: Global Events of Cil Nova Petrochemicals , Krishna Institute Of Medical Sciences .

Company Logo Company Client Name Buy/Sell Qty Traded Price Trader Name
Image is loading Cil Nova Petrochemicals Albula Investment Fund Buy 1M 70.50 New Leaina Investments
Legends Global Opportunities (singapore) Pte Buy 1M 69.74 New Leaina Investments
Lotus Global Investments Sell 1M 70.50 Legends Global Opportunities (singapore) Pte
New Leaina Investments Sell 1M 69.74 Legends Global Opportunities (singapore) Pte
Image is loading Krishna Institute Of Medical Sciences Emerald Investments Sell 1M 2497.00 Infinity Partners
Image is loading Gmm Pfaudler Geranium Investments Sell 3M 1352.00 Nk Securities Research Private
Image is loading Adf Foods Infinity Holdings Sell 1M 269.24 Infinity Portfolio Holdings
Image is loading Vipul Moneyplant Gold & Jewellery Trading Llc Buy 1M 36.90 Srestha Finvest
Image is loading Tcns Clothing Co Morgan Stanley Asia Singapore Pte Sell 353K 576.18 Religare Invesco Mutual Fund
Nomura Singapore Sell 320K 578.13 Religare Invesco Mutual Fund
Image is loading Shaily Engineering Plastics Motilal Oswal Mutual Fund Buy 311K 923.63 Rba Finance And Investment Company
Image is loading Kesoram Industries Sg Sundae Holdings Llc Sell 2M 207.02 Na

The 1M shares of Cil Nova Petrochemicals have been purchased by the by Albula Investment Fund through Foreign Investments at a price of ₹70.50 per share and it is sold by New Leaina Investments at a price of ₹70.50 per share.
The 1M shares of Krishna Institute Of Medical Sciences have been sold by the by Emerald Investments through Foreign Investments at a price of ₹2497.00 per share and it is purchased by Infinity Partners at a price of ₹2497.00 per share.
The 3M shares of Gmm Pfaudler have been sold by the by Geranium Investments through Foreign Investments at a price of ₹1352.00 per share and it is purchased by Nk Securities Research Private at a price of ₹1352.00 per share.
The 1M shares of Adf Foods have been sold by the by Infinity Holdings through Foreign Investments at a price of ₹269.24 per share and it is purchased by Infinity Portfolio Holdings at a price of ₹269.24 per share.
The 1M shares of Cil Nova Petrochemicals have been purchased by the by Legends Global Opportunities (singapore) Pte through Foreign Investments at a price of ₹69.74 per share and it is sold by New Leaina Investments at a price of ₹69.74 per share.
The 1M shares of Cil Nova Petrochemicals have been sold by the by Lotus Global Investments through Foreign Investments at a price of ₹70.50 per share and it is purchased by Legends Global Opportunities (singapore) Pte at a price of ₹70.50 per share.
The 1M shares of Vipul have been purchased by the by Moneyplant Gold & Jewellery Trading Llc through Foreign Investments at a price of ₹36.90 per share and it is sold by Srestha Finvest at a price of ₹36.90 per share.
The 353K shares of Tcns Clothing Co have been sold by the by Morgan Stanley Asia Singapore Pte through Foreign Investments at a price of ₹576.18 per share and it is purchased by Religare Invesco Mutual Fund at a price of ₹576.18 per share.
The 311K shares of Shaily Engineering Plastics have been purchased by the by Motilal Oswal Mutual Fund through Foreign Investments at a price of ₹923.63 per share and it is sold by Rba Finance And Investment Company at a price of ₹923.63 per share.
The 1M shares of Cil Nova Petrochemicals have been sold by the by New Leaina Investments through Foreign Investments at a price of ₹69.74 per share and it is purchased by Legends Global Opportunities (singapore) Pte at a price of ₹69.74 per share.
The 320K shares of Tcns Clothing Co have been sold by the by Nomura Singapore through Foreign Investments at a price of ₹578.13 per share and it is purchased by Religare Invesco Mutual Fund at a price of ₹578.13 per share.
The 2M shares of Kesoram Industries have been sold by the by Sg Sundae Holdings Llc through Foreign Investments at a price of ₹207.02 per share.

The 330K shares of Adani Green Energy have been purchased by the by Citigroup Global Markets Singapore Pte through Foreign Investments at a price of ₹1855.00 per share and it is sold by Citigroup Global Markets Mauritius Private at a price of ₹1855.00 per share.
The 1M shares of Krishna Institute Of Medical Sciences have been sold by the by Emerald Investments through Foreign Investments at a price of ₹2497.00 per share and it is purchased by Infinity Partners at a price of ₹2497.00 per share.
The 3M shares of Gmm Pfaudler have been sold by the by Geranium Investments through Foreign Investments at a price of ₹1352.00 per share and it is purchased by Infinity Partners at a price of ₹1352.00 per share.
The 1M shares of Adf Foods have been sold by the by Infinity Holdings through Foreign Investments at a price of ₹269.24 per share and it is purchased by Infinity Portfolio Holdings at a price of ₹269.24 per share.
The 843K shares of Shanti Educational Initiatives have been purchased by the by Legends Global Opportunities (singapore) Pte through Foreign Investments at a price of ₹124.9 per share and it is sold by New Leaina Investments at a price of ₹124.9 per share.
The 843K shares of Shanti Educational Initiatives have been sold by the by New Leaina Investments through Foreign Investments at a price of ₹124.9 per share and it is purchased by Legends Global Opportunities (singapore) Pte at a price of ₹124.9 per share.

CIL Nova Petrochemicals Limited

0.00

Net Sales

-2.97

Net Profit

32.67

Total Income

-32.23

Expenditure

32.5

Current Price

88.1

Market Cap



The financial snapshot for CIL Nova Petrochemicals Limited reveals a noteworthy performance this quarter. Net sales amounted to ₹0.00 million and total income was ₹32.67 million. The company's expenditure was ₹-32.23 million, leading to a net profit of ₹-2.97 million. Earnings per Share (EPS) for continuing operations were ₹-0.11. The report also highlights other income of ₹0.00 million, finance costs of ₹-0.07 million, and employee benefit expenses of ₹-2.38 million. Depreciation and amortization costs were ₹-3.57 million, while current and deferred taxes were ₹0.00 million and ₹-3.42 million, respectively. The total comprehensive income for the period stood at ₹0.00 million, with other comprehensive income net of taxes at ₹0.00 million.

The company has a market capitalization of ₹88.1 crore and a current stock price of ₹32.5. Historically, the stock has fluctuated between ₹40.0 / 16.1. With a Price-to-Earnings (P/E) ratio of , the stock appears highly valued. The book value per share is ₹32.8, and the dividend yield is 0.00%. The Return on Capital Employed (ROCE) is -3.35% and the Return on Equity (ROE) is -3.68%. The debt-to-equity ratio is very low at 0.20, although the company reports a net cash flow of ₹0.44 crore. The Piotroski score is 3.00, and the Graham Number estimates the intrinsic value of the stock at ₹14.8. The Price-to-Book (P/B) ratio is 0.99, indicating the stock is trading at a premium relative to its book value.

SELLWIN TRADERS LIMITED

166.36

Net Sales

7.00

Net Profit

166.36

Total Income

-157.42

Expenditure

24.4

Current Price

49.4

Market Cap



For SELLWIN TRADERS LIMITED, the latest financial data showcases impressive results. The company reported net sales of ₹166.36 million and total income of ₹166.36 million for the quarter. Expenditure was ₹-157.42 million, resulting in a net profit of ₹7.00 million. EPS for continuing operations was ₹0.35. Additional financial details include other income of ₹0.00 million, finance costs of ₹0.00 million, and employee benefit expenses of ₹-0.23 million. Depreciation and amortization expenses were ₹0.00 million. Current tax was ₹-1.94 million and deferred tax amounted to ₹0.00 million. Total comprehensive income for the period was ₹7.00 million, with other comprehensive income net of taxes at ₹0.00 million.

The company has a market capitalization of ₹49.4 crore and a current stock price of ₹24.4. Historically, the stock has fluctuated between ₹29.5 / 9.50. With a Price-to-Earnings (P/E) ratio of 54.3, the stock appears highly valued. The book value per share is ₹33.4, and the dividend yield is 0.00%. The Return on Capital Employed (ROCE) is 5.66% and the Return on Equity (ROE) is 4.28%. The debt-to-equity ratio is very low at 0.01, although the company reports a net cash flow of ₹2.67 crore. The Piotroski score is 6.00, and the Graham Number estimates the intrinsic value of the stock at ₹28.9. The Price-to-Book (P/B) ratio is 0.73, indicating the stock is trading at a premium relative to its book value.

Krishna Institute of Medical Sciences Limited

6,884.00

Net Sales

952.00

Net Profit

6,930.00

Total Income

5,659.00

Expenditure

2,637

Current Price

21,103

Market Cap



In Krishna Institute of Medical Sciences Limited's recent financial report, the data highlights a robust performance. Net sales reached ₹6,884.00 million, with total income of ₹6,930.00 million. The expenditure was ₹5,659.00 million, leading to a net profit of ₹952.00 million. Earnings per Share (EPS) for continuing operations were reported at ₹10.82. The financial overview also includes other income of ₹46.00 million, finance costs of ₹179.00 million, and employee benefit expenses totaling ₹1,186.00 million. Depreciation and amortization expenses were ₹390.00 million. Current and deferred taxes were recorded at ₹338.00 million and ₹-19.00 million, respectively. The total comprehensive income for the period was ₹953.00 million, and other comprehensive income net of taxes was ₹1.00 million.

Currently valued at ₹21,103 crore, the company's stock price is ₹2,637. It has seen a price range of ₹2,708 / 1,625 over time. The stock's Price-to-Earnings (P/E) ratio is notably high at 66.8, implying a strong valuation. The book value per share is ₹228 and the dividend yield is 0.00%. ROCE is recorded at 16.9%, and ROE stands at 17.6%. The company maintains a very low debt-to-equity ratio of 0.74, though it has a negative net cash flow of ₹-14.7 crore. The Piotroski score of 4.00 and the Graham Number of ₹450 suggest some caution, while the Price-to-Book (P/B) ratio of 11.5 reflects a premium valuation.

GMM Pfaudler Ltd.

7.00

Net Sales

238.80

Net Profit

7.00

Total Income

-7.00

Expenditure

1,425

Current Price

6,407

Market Cap



The financial snapshot for GMM Pfaudler Ltd. reveals a noteworthy performance this quarter. Net sales amounted to ₹7.00 million and total income was ₹7.00 million. The company's expenditure was ₹-7.00 million, leading to a net profit of ₹238.80 million. Earnings per Share (EPS) for continuing operations were ₹5.62. The report also highlights other income of ₹100.40 million, finance costs of ₹-250.00 million, and employee benefit expenses of ₹-2.00 million. Depreciation and amortization costs were ₹-324.30 million, while current and deferred taxes were ₹-235.70 million and ₹63.10 million, respectively. The total comprehensive income for the period stood at ₹164.90 million, with other comprehensive income net of taxes at ₹-73.90 million.

The company's market cap is ₹6,407 crore, with a stock price of ₹1,425. The historical stock range has been between ₹1,898 / 1,143. Its Price-to-Earnings (P/E) ratio of 42.5 indicates a high valuation. The book value per share is ₹215, and it has a dividend yield of 0.14%. The ROCE is 19.1% and ROE is 19.6%. With a very low debt-to-equity ratio of 0.94, the company is minimally leveraged. However, it reports a negative net cash flow of ₹8.15 crore. The Piotroski score of 8.00 and the Graham Number of ₹410 show mixed financial indicators, while the Price-to-Book (P/B) ratio of 6.62 suggests the stock is trading at a premium.

ADF Foods Limited.

1.00

Net Sales

143.86

Net Profit

1.00

Total Income

-1.00

Expenditure

271

Current Price

2,981

Market Cap



The latest financial figures for ADF Foods Limited. indicate a strong performance. The company achieved net sales of ₹1.00 million and total income of ₹1.00 million for the quarter. Expenditure was ₹-1.00 million, resulting in a net profit of ₹143.86 million. Earnings per Share (EPS) for continuing operations stood at ₹1.37. The report also shows other income of ₹49.69 million, finance costs of ₹-6.05 million, and employee benefit expenses of ₹-82.80 million. Depreciation and amortization expenses totaled ₹-44.13 million. Current tax expense was ₹-54.61 million and deferred tax expense was ₹2.86 million. Total comprehensive income for the period was ₹145.30 million, with other comprehensive income net of taxes at ₹1.44 million.

With a market capitalization of ₹2,981 crore, the company’s stock is currently priced at ₹271. The historical trading range of the stock is ₹280 / 179. The P/E ratio is remarkably high at 40.6, suggesting a significant valuation. The book value stands at ₹40.2, and the dividend yield is 0.44%. The Return on Capital Employed (ROCE) is 19.5%, and the Return on Equity (ROE) is 16.3%. The debt-to-equity ratio is very low at 0.13, though the company shows a negative net cash flow of ₹19.8 crore. The Piotroski score is 7.00, with the Graham Number pegged at ₹78.7. The Price-to-Book (P/B) ratio of 6.74 highlights a premium valuation.

Vipul Limited

158.57

Net Sales

18.09

Net Profit

185.49

Total Income

-167.78

Expenditure

34.6

Current Price

487

Market Cap



In Vipul Limited's recent financial report, the data highlights a robust performance. Net sales reached ₹158.57 million, with total income of ₹185.49 million. The expenditure was ₹-167.78 million, leading to a net profit of ₹18.09 million. Earnings per Share (EPS) for continuing operations were reported at ₹0.15. The financial overview also includes other income of ₹26.92 million, finance costs of ₹-36.10 million, and employee benefit expenses totaling ₹-22.75 million. Depreciation and amortization expenses were ₹-6.88 million. Current and deferred taxes were recorded at ₹0.00 million and ₹0.00 million, respectively. The total comprehensive income for the period was ₹18.09 million, and other comprehensive income net of taxes was ₹0.00 million.

Currently valued at ₹487 crore, the company's stock price is ₹34.6. It has seen a price range of ₹53.0 / 13.2 over time. The stock's Price-to-Earnings (P/E) ratio is notably high at 1.93, implying a strong valuation. The book value per share is ₹29.3 and the dividend yield is 0.00%. ROCE is recorded at 66.1%, and ROE stands at 98.1%. The company maintains a very low debt-to-equity ratio of 0.53, though it has a negative net cash flow of ₹-43.4 crore. The Piotroski score of 7.00 and the Graham Number of ₹117 suggest some caution, while the Price-to-Book (P/B) ratio of 1.18 reflects a premium valuation.

TCNS Clothing Co. Limited

2,061.64

Net Sales

-597.44

Net Profit

2,097.58

Total Income

2,893.16

Expenditure

542

Current Price

3,434

Market Cap



The financial snapshot for TCNS Clothing Co. Limited reveals a noteworthy performance this quarter. Net sales amounted to ₹2,061.64 million and total income was ₹2,097.58 million. The company's expenditure was ₹2,893.16 million, leading to a net profit of ₹-597.44 million. Earnings per Share (EPS) for continuing operations were ₹-9.42. The report also highlights other income of ₹35.94 million, finance costs of ₹161.14 million, and employee benefit expenses of ₹421.32 million. Depreciation and amortization costs were ₹272.30 million, while current and deferred taxes were ₹0.00 million and ₹-198.14 million, respectively. The total comprehensive income for the period stood at ₹-591.32 million, with other comprehensive income net of taxes at ₹6.12 million.

With a market capitalization of ₹3,434 crore, the company’s stock is currently priced at ₹542. The historical trading range of the stock is ₹579 / 327. The P/E ratio is remarkably high at , suggesting a significant valuation. The book value stands at ₹47.9, and the dividend yield is 0.00%. The Return on Capital Employed (ROCE) is -28.7%, and the Return on Equity (ROE) is -63.1%. The debt-to-equity ratio is very low at 2.00, though the company shows a negative net cash flow of ₹-21.0 crore. The Piotroski score is 2.00, with the Graham Number pegged at ₹. The Price-to-Book (P/B) ratio of 11.3 highlights a premium valuation.

Shaily Engineering Plastics Ltd.

1.00

Net Sales

174.10

Net Profit

1.00

Total Income

-1.00

Expenditure

973

Current Price

4,465

Market Cap



In the most recent financial analysis for Shaily Engineering Plastics Ltd., key metrics demonstrate a solid performance. The net sales reached ₹1.00 million, with total income amounting to ₹1.00 million. Expenditure was recorded at ₹-1.00 million, resulting in a net profit of ₹174.10 million. EPS figures for continuing operations are ₹3.80. Other notable figures include other income of ₹7.10 million, finance costs of ₹-43.57 million, and employee benefit expenses totaling ₹-178.87 million. Depreciation and amortization expenses were ₹-101.44 million, with current tax at ₹-23.80 million and deferred tax at ₹-18.44 million. The total comprehensive income for the period was ₹173.26 million, and other comprehensive income net of taxes was ₹-0.84 million.

Currently valued at ₹4,465 crore, the company's stock price is ₹973. It has seen a price range of ₹1,061 / 309 over time. The stock's Price-to-Earnings (P/E) ratio is notably high at 71.9, implying a strong valuation. The book value per share is ₹100 and the dividend yield is 0.10%. ROCE is recorded at 14.1%, and ROE stands at 13.3%. The company maintains a very low debt-to-equity ratio of 0.46, though it has a negative net cash flow of ₹3.08 crore. The Piotroski score of 8.00 and the Graham Number of ₹175 suggest some caution, while the Price-to-Book (P/B) ratio of 9.72 reflects a premium valuation.

Kesoram Industries Limited

8,789.10

Net Sales

-620.20

Net Profit

8,840.30

Total Income

9,256.00

Expenditure

220

Current Price

6,820

Market Cap



The latest financial figures for Kesoram Industries Limited indicate a strong performance. The company achieved net sales of ₹8,789.10 million and total income of ₹8,840.30 million for the quarter. Expenditure was ₹9,256.00 million, resulting in a net profit of ₹-620.20 million. Earnings per Share (EPS) for continuing operations stood at ₹-2.00. The report also shows other income of ₹51.20 million, finance costs of ₹771.70 million, and employee benefit expenses of ₹574.40 million. Depreciation and amortization expenses totaled ₹397.60 million. Current tax expense was ₹0.00 million and deferred tax expense was ₹204.50 million. Total comprehensive income for the period was ₹-613.70 million, with other comprehensive income net of taxes at ₹6.50 million.

Valued at ₹6,820 crore, the company's stock trades at ₹220, with historical highs and lows of ₹227 / 71.3. The P/E ratio of reflects a high stock valuation. The book value is ₹3.05, and the dividend yield is 0.00%. ROCE is at 11.0%, and ROE is -125%. The company’s minimal debt-to-equity ratio of 23.9 contrasts with its negative net cash flow of ₹40.8 crore. The Piotroski score is 5.00, and the Graham Number of ₹ provides insight into the stock’s valuation. The Price-to-Book (P/B) ratio of 71.9 indicates a premium valuation.

Join our telegram for more updates

Stay Updated with Our YouTube Videos

Related Post